| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $162.0M | +3.3% |
| Cost of Revenue | $71.5M | -5.6% |
| Gross Profit | $90.5M | +11.6% |
| R&D Expense | $46.1M | -43.5% |
| SG&A Expense | $50.6M | -28.5% |
| Operating Income | -$49.6M | +68.2% |
| Pre-tax Income | -$43.3M | +75.9% |
| Income Tax | $109K | +16.0% |
| Net Income | -$43.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $42.2M | +36.4% |
| Short-term Investments | $56.2M | -46.9% |
| Accounts Receivable | $17.4M | -5.3% |
| Current Assets | $135.2M | -20.4% |
| Total Assets | $178.0M | -13.6% |
| Current Liabilities | $38.9M | +23.4% |
| Long-term Debt | $0 | -100.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.0M | +89.8% |
| Investing Cash Flow | $45.4M | -64.3% |
| Financing Cash Flow | -$21.1M | +76.8% |
| +75.7% |
| EPS (Basic) | -$0.24 | +68.4% |
| EPS (Diluted) | -$0.24 | +68.4% |
| Total Liabilities |
| $40.3M |
| -77.5% |
| Stockholders' Equity | -$56.4M | -192.9% |